Differential expression of the bcl-2 oncogene in human basal cell carcinoma

Human Pathology

Volumn 27, Issue 4, 1996, Pages 355-359

  Crowson, A N ^b   Magro, C M ^a   Kadin, M E ^b   Stranc, M ^b  

^a Pathology Services Inc Cambridge   (United States)

^b NONE

Author keywords

BCC; bcl 2; differential expression; oncogene

Indexed keywords

GENE PRODUCT; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER GRADING; CELL DEATH; CELL NUCLEUS MEMBRANE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LONGEVITY; LUNG NON SMALL CELL CANCER; OVARY FOLLICLE CELL; PROSTATE CANCER;

EID: 0029989216     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90108-2     Document Type: Article

References (43)

1. Hockenbery D, Zutter M, Hickey W, et al: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88:6961-6965, 1991
2. Hockenbery D, Nunez G, Milliman C, et al: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
3. Monaghan P, Robertson D, Amos AS, et al: Ultrastructural localization of BCL-2 protein. J Histochem Cytochem 40:1819-1825, 1992
4. Alnemri ES, Robertson NM, Fernandes TF, et al: Overexpressed full-length BCL2 extends the survival of baculovirus-infected Sf9 insect cells. Proc Natl Acad Sci USA 89:7295-7299, 1992
5. Jacobson MD, Burne JF, King MP, et al: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365-368, 1993
6. Delia D, Aiello A, Soligo D, et al: bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79:1291-1298, 1992
7. Vaux DL, Gory S, Adams JM: Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442, 1988
8. Korsmeyer SJ, Shutter JR, Veisn DJ, et al: Bcl-2/BAX: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4:327-332, 1993
9. 2+ fluxes. Proc Natl Acad Sci U S A 91:6569-6573, 1994
10. Oltvai ZN, Korsmeyer SJ: Checkpoints of dueling dimers foil death wishes. Cell 79:189-192, 1994
11. Schena M, Larsson L-G, Gottardi D, et al: Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79:2981-2989, 1992
12. Gaulard P, d'Agay M-F, Peuchmaur M, et al: Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 140:1089-1095, 1992
13. Pezzella F, Gatter KC, Mason DY, et al: bcl-2 protein expression in follicular lymphomas in absence of t14; 18 translocation. Lancet 336:1510-1511, 1990
14. Jiwa NM, Kanavaros P, van der Valk P, et al: Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J Clin Pathol 46:211-217, 1993
15. Cerroni L, Soyer HP, Kerl H: bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi. Am J Dermatopathol 17:7-11, 1995
16. Pezzella F, Turley H, Kuzu I, et al: bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993
17. Ben-Ezra JM, Kornstein MJ, Grimes MM, et al: Small cell carcinomas of the lung express the Bcl-2 protein. Am J Pathol 145:1036-1040, 1994
18. Lu QL, Elia G, Lucas S, et al: Bcl-2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 53:29-35, 1993
19. McDonnell TJ, Troncoso P, Brisbay SM, et al: Expression of the protooncogene bcl-2 in the prostate and its association with the emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944, 1992
20. Ngan B-Y, Chen-Levy Z, Weiss LM, et al: Expression in non-Hodgkin's lymphomas of the bcl-2 protein associated with the t(14:18) chromosomal translocation. N Engl J Med 318:1638-1644, 1988
21. Lu Q-L, Poulsom R, Wong L, et al: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169:431-437, 1993
22. Ponten F, Ren Z, Nister M, et al: Epithelial-stromal interactions in basal cell cancer: The PGDF system. J Inv Dermatol 102:304-309, 1994
23. Sexton M, Jones D, Maloney M: Histological patterns of basal cell carcinoma. J Am Acad Dermatol 23:1118-1126, 1990
24. Lever WF, Schaumburg-Lever G: Histopathology of the Skin, (ed. 7) Philadelphia, PA, Lippincott, 1990, pp 622-634
25. Smoller BR, van de Rijn M, LeBrun D, et al: bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas. Br J Dermatol 131:28-31, 1994
26. Nakagawa K, Yamamura K, Maeda S, et al: bcl-2 expression in epidermal keratinocyte diseases. Cancer 74:1720-1724, 1994
27. Cerroni L, Kerl H: Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal cell carcinoma. J Cutan Pathol 21:398-403, 1994
28. Morales-Ducret CR, van de Rijn M, LeBrun DP, et al: bcl-2 expression in primary malignancies of the skin. Arch Dermatol 131:915-198, 1995
29. Weinstein GD, Frost P: Cell proliferation in human basal cell carcinoma. Cancer Res 30:724-728, 1970
30. Heenen M, Galand P: Cell population kinetics in human epidermis: In vitro autoradiographic study by double-labelling method. J Invest Dermatol 56:425-429, 1971
31. Galand P, Heenan M: DNA replication fork progression rate and temporal organization of S phase in normal epidermis and in basal cell carcinoma. J Cell Physiol 137:374-377, 1988
32. Heenen M, Galand P: Decreased rate of DNA-chain growth in human basal cell carcinoma. Nature 285:265-267, 1980
33. Heenen M, Achten G, Galand P: Autoradiographic analysis of cell kinetics in human normal epidermis and basal cell carcinoma. Cancer Res 33:123-127, 1973
34. McDonnell TJ, Deane N, Platt FM, et al: bcl-2-immunoglobulin transgeneic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79-88, 1989
35. McDonnell TJ, Nunez G, Platt FM, et al: Deregulated bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobuilin M and D-expressing B-cell population. Mol Cell Biol 10:1901-1907, 1990
36. McDonnell TJ, Kormeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgeneic for the t(14:18). Nature 349:254-256, 1991
37. Strasser A, Harris AW, Bath ML, et al: Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331-333, 1990
38. Rady P, Scinicariello F, Wagner RF, et al: p53 Mutations in basal cell carcinoma. Cancer Res 52:3804-3806, 1992
39. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554-556, 1992
40. Seki H, Iwai K, Kanegane H, et al: Differential protective action of cytokines on radiation-induced apoptosis of peripheral lymphocyte subpopulations. Cell Immunol 163:30-36, 1995
41. Tsukada T, Eguchi K, Migita K, et al: Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem Biophys Res Commun 210:1076-1082, 1995
42. Weller M, Constam DB, Malipiero U, et al: Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression. Eur J Immunol 24:1293-1300, 1994
43. Salmon M, Pilling D, Borthwick NJ, et al: The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 24:892-899, 1994